Cargando…

Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India

OBJECTIVE: To describe the clinical and laboratory profile, management, intensive care needs, and outcome of children with toxic shock syndrome (TSS) admitted to the pediatric intensive care unit (PICU) of a tertiary care center in North India. METHODS: This retrospective study was conducted in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Angurana, Suresh Kumar, Awasthi, Puspraj, K.C., Sudeep, Nallasamy, Karthi, Bansal, Arun, Jayashree, Muralidharan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266086/
https://www.ncbi.nlm.nih.gov/pubmed/35804287
http://dx.doi.org/10.1007/s12098-022-04271-4
_version_ 1784743376803856384
author Angurana, Suresh Kumar
Awasthi, Puspraj
K.C., Sudeep
Nallasamy, Karthi
Bansal, Arun
Jayashree, Muralidharan
author_facet Angurana, Suresh Kumar
Awasthi, Puspraj
K.C., Sudeep
Nallasamy, Karthi
Bansal, Arun
Jayashree, Muralidharan
author_sort Angurana, Suresh Kumar
collection PubMed
description OBJECTIVE: To describe the clinical and laboratory profile, management, intensive care needs, and outcome of children with toxic shock syndrome (TSS) admitted to the pediatric intensive care unit (PICU) of a tertiary care center in North India. METHODS: This retrospective study was conducted in the PICU of a tertiary care hospital in North India over a period of 10 y (January 2011–December 2020) including children < 12 y with TSS (n = 63). RESULTS: The median (interquartile range, IQR) age was 5 (2–9) y, 58.7% were boys, and Pediatric Risk of Mortality III (PRISM-III) score was 15 (12–17). The primary focus of infection was identified in 60.3% children, 44.5% had skin and soft tissue infections, and 17.5% (n = 11) had growth of Staphylococcus aureus. Common manifestations were shock (100%), rash (95.2%), thrombocytopenia (79.4%), transaminitis (66.7%), coagulopathy (58.7%), and acute kidney injury (AKI) (52.4%); and involvement of gastrointestinal (61.9%), mucus membrane (55.5%), respiratory (47.6%), musculoskeletal (41.3%), and central nervous system (CNS) (31.7%). The treatment included fluid resuscitation (100%), vasoactive drugs (92.1%), clindamycin (96.8%), intravenous immunoglobulin (IVIG) (92.1%), blood products (74.6%), mechanical ventilation (58.7%), and renal replacement therapy (31.7%). The mortality was 27% (n = 17). The duration of PICU and hopsital stay was 5 (4–10) and 7 (4–11) d, respectively. Higher proportion of nonsurvivors had CNS involvement, transaminitis, thrombocytopenia, coagulopathy, and AKI; required mechanical ventilation and blood products; and had higher vasoactive–inotropic score. CONCLUSION: TSS is not uncommon in children in Indian setup. The management includes early recognition, intensive care, antibiotics, source control, and adjunctive therapy (IVIG and clindamycin). Multiorgan dysfunction and need for organ supportive therapies predicted mortality.
format Online
Article
Text
id pubmed-9266086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-92660862022-07-11 Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India Angurana, Suresh Kumar Awasthi, Puspraj K.C., Sudeep Nallasamy, Karthi Bansal, Arun Jayashree, Muralidharan Indian J Pediatr Original Article OBJECTIVE: To describe the clinical and laboratory profile, management, intensive care needs, and outcome of children with toxic shock syndrome (TSS) admitted to the pediatric intensive care unit (PICU) of a tertiary care center in North India. METHODS: This retrospective study was conducted in the PICU of a tertiary care hospital in North India over a period of 10 y (January 2011–December 2020) including children < 12 y with TSS (n = 63). RESULTS: The median (interquartile range, IQR) age was 5 (2–9) y, 58.7% were boys, and Pediatric Risk of Mortality III (PRISM-III) score was 15 (12–17). The primary focus of infection was identified in 60.3% children, 44.5% had skin and soft tissue infections, and 17.5% (n = 11) had growth of Staphylococcus aureus. Common manifestations were shock (100%), rash (95.2%), thrombocytopenia (79.4%), transaminitis (66.7%), coagulopathy (58.7%), and acute kidney injury (AKI) (52.4%); and involvement of gastrointestinal (61.9%), mucus membrane (55.5%), respiratory (47.6%), musculoskeletal (41.3%), and central nervous system (CNS) (31.7%). The treatment included fluid resuscitation (100%), vasoactive drugs (92.1%), clindamycin (96.8%), intravenous immunoglobulin (IVIG) (92.1%), blood products (74.6%), mechanical ventilation (58.7%), and renal replacement therapy (31.7%). The mortality was 27% (n = 17). The duration of PICU and hopsital stay was 5 (4–10) and 7 (4–11) d, respectively. Higher proportion of nonsurvivors had CNS involvement, transaminitis, thrombocytopenia, coagulopathy, and AKI; required mechanical ventilation and blood products; and had higher vasoactive–inotropic score. CONCLUSION: TSS is not uncommon in children in Indian setup. The management includes early recognition, intensive care, antibiotics, source control, and adjunctive therapy (IVIG and clindamycin). Multiorgan dysfunction and need for organ supportive therapies predicted mortality. Springer India 2022-07-08 2023 /pmc/articles/PMC9266086/ /pubmed/35804287 http://dx.doi.org/10.1007/s12098-022-04271-4 Text en © The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Angurana, Suresh Kumar
Awasthi, Puspraj
K.C., Sudeep
Nallasamy, Karthi
Bansal, Arun
Jayashree, Muralidharan
Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title_full Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title_fullStr Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title_full_unstemmed Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title_short Clinical Profile, Intensive Care Needs, and Short-Term Outcome of Toxic Shock Syndrome Among Children: A 10-Year Single-Centre Experience from North India
title_sort clinical profile, intensive care needs, and short-term outcome of toxic shock syndrome among children: a 10-year single-centre experience from north india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266086/
https://www.ncbi.nlm.nih.gov/pubmed/35804287
http://dx.doi.org/10.1007/s12098-022-04271-4
work_keys_str_mv AT anguranasureshkumar clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia
AT awasthipuspraj clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia
AT kcsudeep clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia
AT nallasamykarthi clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia
AT bansalarun clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia
AT jayashreemuralidharan clinicalprofileintensivecareneedsandshorttermoutcomeoftoxicshocksyndromeamongchildrena10yearsinglecentreexperiencefromnorthindia